Metformin may protect against biochemical failure in localized prostate cancer
Use of metformin appears to confer a risk reduction in biochemical failure in men with localized prostate cancer treated with radical prostatectomy or radiation therapy, a study has found.
Metformin may protect against biochemical failure in localized prostate cancer
08 Feb 2021
